Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$309M |
| 2 |
Enbridge
ENB
|
+$233M |
| 3 |
AT&T
T
|
+$219M |
| 4 |
AGN
Allergan plc
AGN
|
+$211M |
| 5 |
MetLife
MET
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 2 |
Automatic Data Processing
ADP
|
+$694M |
| 3 |
Pembina Pipeline
PBA
|
+$382M |
| 4 |
Toronto Dominion Bank
TD
|
+$293M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.23% |
| 2 | Technology | 8.83% |
| 3 | Energy | 8.24% |
| 4 | Industrials | 7.52% |
| 5 | Communication Services | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVLR
1951
DELISTED
Avalara, Inc.
AVLR
| $5.81M | ﹤0.01% |
86,390
-12,455
| -13% | -$1.01M |
|
1952
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
| $5.8M | ﹤0.01% |
169,969
-24,548
| -13% | -$831K |
|
1953
Regency Centers
REG
$14B
| $5.8M | ﹤0.01% |
83,482
-1,706
| -2% | -$114K |
|
1954
Delek US
DK
$4.03B
| $5.77M | ﹤0.01% |
158,884
-15,127
| -9% | -$557K |
|
1955
PUT
Vale
VALE
$58.1B
| $5.75M | ﹤0.01% |
500,000
-200
| -0% | -$2.42K |
|
1956
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $5.75M | ﹤0.01% |
228,666
+55,138
| +32% | +$1.4M |
|
1957
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $5.74M | ﹤0.01% |
534,299
+8,020
| +2% | +$85.3K |
|
|
DIAX
1958
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $5.74M | ﹤0.01% |
322,148
+17,392
| +6% | +$307K |
|
1959
Vanguard Total World Bond ETF
BNDW
$1.89B
| $5.74M | ﹤0.01% |
71,322
+10,418
| +17% | +$832K |
|
1960
Tilly's
TLYS
$122M
| $5.71M | ﹤0.01% |
605,267
-108,056
| -15% | -$954K |
|
1961
CALL
Nutrien
NTR
$32.6B
| $5.7M | ﹤0.01% |
+114,200
| New | +$5.83M |
|
|
AMED
1962
DELISTED
Amedisys
AMED
| $5.68M | ﹤0.01% |
43,336
-25,711
| -37% | -$3.35M |
|
1963
Unitil
UTL
$995M
| $5.66M | ﹤0.01% |
89,209
+1,940
| +2% | +$116K |
|
1964
First Trust Consumer Staples AlphaDEX Fund
FXG
$233M
| $5.64M | ﹤0.01% |
116,663
+21,094
| +22% | +$988K |
|
1965
Adams Diversified Equity Fund
ADX
$3.29B
| $5.63M | ﹤0.01% |
355,366
-29,857
| -8% | -$468K |
|
|
CS
1966
DELISTED
Credit Suisse Group
CS
| $5.61M | ﹤0.01% |
459,257
-11,238
| -2% | -$135K |
|
1967
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.03B
| $5.6M | ﹤0.01% |
172,668
+51,624
| +43% | +$1.75M |
|
1968
Community Bank
CBU
$3.46B
| $5.6M | ﹤0.01% |
90,717
-4,509
| -5% | -$285K |
|
1969
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $5.59M | ﹤0.01% |
325,000
| – | – |
|
|
1970
PUT
Takeda Pharmaceutical
TAK
$56.3B
| $5.59M | ﹤0.01% |
325,000
| – | – |
|
|
BXMX
1971
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $5.59M | ﹤0.01% |
427,535
+41,398
| +11% | +$541K |
|
1972
iShares Core MSCI Pacific ETF
IPAC
$2.78B
| $5.58M | ﹤0.01% |
99,370
+67,090
| +208% | +$3.71M |
|
1973
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.29B
| $5.58M | ﹤0.01% |
38,574
+20,598
| +115% | +$2.84M |
|
1974
WisdomTree True Developed International Fund
DOL
$848M
| $5.57M | ﹤0.01% |
121,106
-3,730
| -3% | -$171K |
|
1975
Kimco Realty
KIM
$16.3B
| $5.53M | ﹤0.01% |
264,941
-56,997
| -18% | -$1.08M |
|
Similar funds
Royal Bank of Canada's Q3 2019 Portfolio in Review
As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.
- Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
- Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
- Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
- Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
- Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.
Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.